Analysts See $-0.26 EPS for Eyegate Pharmaceuticals, Inc. (EYEG); 9 Analysts Are Bullish Faroe Petroleum plc (LON:FPM) Last Week

January 27, 2018 - By Winifred Garcia

Analysts expect Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) to report $-0.26 EPS on February, 22.They anticipate $0.12 EPS change or 31.58% from last quarter’s $-0.38 EPS. After having $-0.24 EPS previously, Eyegate Pharmaceuticals, Inc.’s analysts see 8.33% EPS growth. The stock decreased 3.33% or $0.04 during the last trading session, reaching $1.16. About 213,800 shares traded. Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) has declined 40.33% since January 27, 2017 and is downtrending. It has underperformed by 57.03% the S&P500.

Among 13 analysts covering Faroe Petroleum (LON:FPM), 9 have Buy rating, 0 Sell and 4 Hold. Therefore 69% are positive. Faroe Petroleum had 117 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Faroe Petroleum plc (LON:FPM) has “Buy” rating given on Wednesday, March 22 by Jefferies. The rating was maintained by Barclays Capital with “Equal Weight” on Tuesday, January 3. Canaccord Genuity maintained Faroe Petroleum plc (LON:FPM) rating on Wednesday, February 3. Canaccord Genuity has “Buy” rating and GBX 90 target. Cantor Fitzgerald maintained it with “Buy” rating and GBX 100 target in Friday, July 15 report. Canaccord Genuity maintained Faroe Petroleum plc (LON:FPM) rating on Wednesday, August 31. Canaccord Genuity has “Buy” rating and GBX 100 target. The company was maintained on Monday, July 11 by Cantor Fitzgerald. Peel Hunt maintained the shares of FPM in report on Tuesday, July 12 with “Buy” rating. Canaccord Genuity maintained the stock with “Buy” rating in Thursday, September 22 report. The stock of Faroe Petroleum plc (LON:FPM) has “Equal Weight” rating given on Tuesday, February 9 by Barclays Capital. The rating was maintained by Barclays Capital on Wednesday, December 21 with “Equal Weight”. See Faroe Petroleum plc (LON:FPM) latest ratings:

15/01/2018 Broker: Barclays Capital Rating: Overweight New Target: GBX 115.00 Maintain
08/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 115.00 New Target: GBX 125.00 Maintain
20/12/2017 Broker: Jefferies Rating: Buy Old Target: GBX 125.00 New Target: GBX 125.00 Maintain
21/11/2017 Broker: Jefferies Rating: Buy New Target: GBX 125.00 Maintain
22/11/2017 Broker: Barclays Capital Rating: Overweight Old Target: GBX 110.00 New Target: GBX 110.00 Maintain
10/11/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 115.00 New Target: GBX 115.00 Maintain
04/10/2017 Broker: Jefferies Rating: Buy Old Target: GBX 125.00 New Target: GBX 125.00 Maintain
02/10/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 115.00 New Target: GBX 115.00 Maintain
27/09/2017 Broker: Jefferies Rating: Buy Old Target: GBX 125.00 New Target: GBX 125.00 Maintain
27/09/2017 Broker: Barclays Capital Rating: Overweight Old Target: GBX 115.00 New Target: GBX 110.00 Maintain

The stock increased 0.71% or GBX 0.8 during the last trading session, reaching GBX 114. About 1.05M shares traded or 46.16% up from the average. Faroe Petroleum plc (LON:FPM) has 0.00% since January 27, 2017 and is . It has underperformed by 16.70% the S&P500.

Faroe Petroleum plc, an independent gas and oil company, engages in the exploration, appraisal, development, and production of gas and oil fields in Northwest Europe. The company has market cap of 417.97 million GBP. It has interests in the Schooner and Ketch gas fields, and the Blane oil field in the United Kingdom; and the Brage, Ringhorne East, Ula, Tambar, Oselvar, and Trym fields in Norway. It currently has negative earnings. As of January 1, 2017, it had proven and probable reserves of 81.3 million barrels of oil equivalent.

Among 2 analysts covering Eyegate Pharmaceuticals (NASDAQ:EYEG), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Eyegate Pharmaceuticals had 2 analyst reports since November 12, 2015 according to SRatingsIntel. The company was initiated on Thursday, November 12 by Maxim Group. The rating was initiated by Chardan Capital Markets with “Buy” on Wednesday, December 23.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>